Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We observed a 1.48-fold increased risk for stomach cancer (95% confidence interval 0.97-2.25) in patients with the GSTT1 null genotype but no evidence of increased risk associated with the GSTM1, GSTM3 or GSTP1 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP931625.RAlr32giY7FLYpjJJRQDBgSPPgoMChwy1-seXVJLT5Kow130_assertion description "[We observed a 1.48-fold increased risk for stomach cancer (95% confidence interval 0.97-2.25) in patients with the GSTT1 null genotype but no evidence of increased risk associated with the GSTM1, GSTM3 or GSTP1 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP931625.RAlr32giY7FLYpjJJRQDBgSPPgoMChwy1-seXVJLT5Kow130_provenance.
• assertion description "[We observed a 1.48-fold increased risk for stomach cancer (95% confidence interval 0.97-2.25) in patients with the GSTT1 null genotype but no evidence of increased risk associated with the GSTM1, GSTM3 or GSTP1 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP50776.RAaXHkOvje6nkGeclGwbicvjKJqFz5cK-HiSt-DMYGqPI130_assertion description "[We observed a 1.48-fold increased risk for stomach cancer (95% confidence interval 0.97-2.25) in patients with the GSTT1 null genotype but no evidence of increased risk associated with the GSTM1, GSTM3 or GSTP1 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP50776.RAaXHkOvje6nkGeclGwbicvjKJqFz5cK-HiSt-DMYGqPI130_provenance.
• assertion description "[We observed a 1.48-fold increased risk for stomach cancer (95% confidence interval 0.97-2.25) in patients with the GSTT1 null genotype but no evidence of increased risk associated with the GSTM1, GSTM3 or GSTP1 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We observed a 1.48-fold increased risk for stomach cancer (95% confidence interval 0.97-2.25) in patients with the GSTT1 null genotype but no evidence of increased risk associated with the GSTM1, GSTM3 or GSTP1 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP585984.RAK0vm2tgnqzSNNO-ETaIF3YaZCKDpqL327zLvYr2TZBA130_assertion description "[We observed a 1.48-fold increased risk for stomach cancer (95% confidence interval 0.97-2.25) in patients with the GSTT1 null genotype but no evidence of increased risk associated with the GSTM1, GSTM3 or GSTP1 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP585984.RAK0vm2tgnqzSNNO-ETaIF3YaZCKDpqL327zLvYr2TZBA130_provenance.
• NP51006.RAiREA2m5eEwnZzP-kvr1CsbeQmZgUOnOCJi3wt8hvBD8130_assertion description "[We observed a 1.48-fold increased risk for stomach cancer (95% confidence interval 0.97-2.25) in patients with the GSTT1 null genotype but no evidence of increased risk associated with the GSTM1, GSTM3 or GSTP1 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP51006.RAiREA2m5eEwnZzP-kvr1CsbeQmZgUOnOCJi3wt8hvBD8130_provenance.
• NP71838.RAVa_LYEUF7PHykgZDNZ9kPxTUcD21etiEPQzyTyRZrzw130_assertion description "[We observed a 1.48-fold increased risk for stomach cancer (95% confidence interval 0.97-2.25) in patients with the GSTT1 null genotype but no evidence of increased risk associated with the GSTM1, GSTM3 or GSTP1 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP71838.RAVa_LYEUF7PHykgZDNZ9kPxTUcD21etiEPQzyTyRZrzw130_provenance.
• NP439015.RAC-7KQN1rnwkxXAnEsk8Pk2H3WEX9yHiSeKMUlKUwB2U130_assertion description "[We observed a 1.48-fold increased risk for stomach cancer (95% confidence interval 0.97-2.25) in patients with the GSTT1 null genotype but no evidence of increased risk associated with the GSTM1, GSTM3 or GSTP1 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP439015.RAC-7KQN1rnwkxXAnEsk8Pk2H3WEX9yHiSeKMUlKUwB2U130_provenance.
• NP335206.RARCwCB_L7fgQqgQ_WVb4deKFNmIq8SpbeU2hsdOrdqa4130_assertion description "[We observed a 1.48-fold increased risk for stomach cancer (95% confidence interval 0.97-2.25) in patients with the GSTT1 null genotype but no evidence of increased risk associated with the GSTM1, GSTM3 or GSTP1 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335206.RARCwCB_L7fgQqgQ_WVb4deKFNmIq8SpbeU2hsdOrdqa4130_provenance.
• NP335210.RARTZ5Ih-gxDnPe44Jy1KGKLip9RFwuCqIwOJQwVWPExs130_assertion description "[We observed a 1.48-fold increased risk for stomach cancer (95% confidence interval 0.97-2.25) in patients with the GSTT1 null genotype but no evidence of increased risk associated with the GSTM1, GSTM3 or GSTP1 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335210.RARTZ5Ih-gxDnPe44Jy1KGKLip9RFwuCqIwOJQwVWPExs130_provenance.
• NP335211.RAbl4P5LQfmxF5G9m1zK8r0v-SiBD9iKSeDXh-H_O_UEE130_assertion description "[We observed a 1.48-fold increased risk for stomach cancer (95% confidence interval 0.97-2.25) in patients with the GSTT1 null genotype but no evidence of increased risk associated with the GSTM1, GSTM3 or GSTP1 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335211.RAbl4P5LQfmxF5G9m1zK8r0v-SiBD9iKSeDXh-H_O_UEE130_provenance.
• NP71836.RAr8IxVslXb-xK_jBWJUCTMgXOZEvqGQgrWjC3yala7dw130_assertion description "[We observed a 1.48-fold increased risk for stomach cancer (95% confidence interval 0.97-2.25) in patients with the GSTT1 null genotype but no evidence of increased risk associated with the GSTM1, GSTM3 or GSTP1 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP71836.RAr8IxVslXb-xK_jBWJUCTMgXOZEvqGQgrWjC3yala7dw130_provenance.
• NP50687.RAG0q5gGmgMC3wDC9837NQr8Beq4LuLg_bcUzzu6cDvMo130_assertion description "[We observed a 1.48-fold increased risk for stomach cancer (95% confidence interval 0.97-2.25) in patients with the GSTT1 null genotype but no evidence of increased risk associated with the GSTM1, GSTM3 or GSTP1 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP50687.RAG0q5gGmgMC3wDC9837NQr8Beq4LuLg_bcUzzu6cDvMo130_provenance.
• NP335209.RArTWwwYWzvQnPJluJU6O7bRAXIuNizYTX-pIk9g0sxy8130_assertion description "[We observed a 1.48-fold increased risk for stomach cancer (95% confidence interval 0.97-2.25) in patients with the GSTT1 null genotype but no evidence of increased risk associated with the GSTM1, GSTM3 or GSTP1 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335209.RArTWwwYWzvQnPJluJU6O7bRAXIuNizYTX-pIk9g0sxy8130_provenance.
• NP71837.RAGuusRV3eG464gFFcEEtKgIRy_CgvaSKE7NS54Z2L3_w130_assertion description "[We observed a 1.48-fold increased risk for stomach cancer (95% confidence interval 0.97-2.25) in patients with the GSTT1 null genotype but no evidence of increased risk associated with the GSTM1, GSTM3 or GSTP1 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP71837.RAGuusRV3eG464gFFcEEtKgIRy_CgvaSKE7NS54Z2L3_w130_provenance.
• NP335205.RA7qYl4zB7vYyN6fQovTjEU1sjktZ9aQcWCBSmekNEX-Y130_assertion description "[We observed a 1.48-fold increased risk for stomach cancer (95% confidence interval 0.97-2.25) in patients with the GSTT1 null genotype but no evidence of increased risk associated with the GSTM1, GSTM3 or GSTP1 genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335205.RA7qYl4zB7vYyN6fQovTjEU1sjktZ9aQcWCBSmekNEX-Y130_provenance.